- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Stage II Multiple Myeloma
Explore clinical trials studying Stage II Multiple Myeloma. Study availability and eligibility vary by location and protocol.
43 public trials
0 recruiting studies
Stage II Multiple Myeloma trial results
NCT00014235
- Conditions
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
- Locations
-
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Conditions
- Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +87 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Universitaet Leipzig Leipzig, Germany
NCT00002787
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant
NCT01706666
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Baylor Medical Center Garland, Texas, United States
NCT01273766
- Conditions
- Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
NCT01053494
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
NCT01057225
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
- Medical University of South Carolina Charleston, South Carolina, United States
NCT00410605
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States